James F. Parslow
CIK: 0001285943
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
XBIO
Xenetic Biosciences, Inc.
Officer
Discretionary Trading P&L
Holdings
About PARSLOW JAMES F
PARSLOW JAMES F (SEC CIK 0001285943) files insider reports with the SEC as Interim CEO and CFO of Xenetic Biosciences, Inc. (XBIO).
Signal8 holds 1 ownership filing by PARSLOW JAMES F, a Form 4, filed on Apr 23, 2026. Those filings report 1 transaction, the latest on Apr 21, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on PARSLOW JAMES F's filings is in FRAMINGHAM, MA.
Recent filings by PARSLOW JAMES F
- Apr 21, 2026: Grant or award of XBIO shares (Form 4, code A).
Other insiders filing for Xenetic Biosciences, Inc. (XBIO)
- VINOGRADOV ALEXEY ANDREEVICH, Director
- Dastoor Firdaus J., Director
- Kornberg Roger D., Director
- Borisenko Grigory G., Director